Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SIGA Technologies (SIGA US)
Watchlist
22
Analysis
Health Care
•
United States
SIGA Technologies, Inc. operates as a commercial-stage pharmaceutical company. The Company offers oral formulation of an antiviral drug for the treatment of human smallpox disease caused by variola virus.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SIGA Technologies
•
05 Jul 2023 22:38
•
Issuer-paid
SIGA Technologies - Diamond in the rough amid macro weakness
Ahead of its H123 results and an anticipated period of increased business activity in the second half of the year, we present a preview of SIGA...
Edison Investment Research
Follow
315 Views
Share
bullish
•
SIGA Technologies
•
12 May 2023 23:26
•
Issuer-paid
SIGA Technologies - US stockpiles front and center in Q1 and FY23
SIGA’s Q123 results were largely driven by US TPOXX deliveries under existing contracts. Q123 product revenues of $5.7m ($7.3m in Q122) were...
Edison Investment Research
Follow
14 Views
Share
bullish
•
SIGA Technologies
•
14 Mar 2023 16:12
•
Issuer-paid
SIGA Technologies - Solid results marked by revenue diversification
SIGA’s FY22 results highlighted underlying revenue diversification and clinical progression during the year. Results were broadly in line with our...
Edison Investment Research
Follow
229 Views
Share
bullish
•
SIGA Technologies
•
04 Nov 2022 16:55
•
Issuer-paid
SIGA Technologies - Solid Q322, underpinned by international traction
SIGA reported robust Q322 results, with sales momentum driven by international deliveries of oral TPOXX as governments expedited stockpiling to...
Edison Investment Research
Follow
247 Views
Share
bullish
•
SIGA Technologies
•
14 Oct 2022 16:00
•
Issuer-paid
SIGA Technologies - TPOXX trials launched in treating monkeypox
SIGA Technologies has shared an update on the progress of three clinical trials assessing TPOXX for treating monkeypox. Recently, three randomized,...
Edison Investment Research
Follow
668 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x